Other drugs used for treatment of PD (i.e., l-DOPA, monoamine oxidase B (MAO-B) inhibitors, catechol-O-methyltransferase (COMT) inhibitors, and the dopamine receptor agonists ropinirole and pramipexole) have not shown such properties [163]. The gene discussed is MAOB; the disease is Parkinson disease.